Karmanos Cancer Insitute

Detroit, Michigan 48201

Use our guide to learn which trials are right for you!

We've found
2 trials
at this facility
Hematology, Oncology Clinical Trial
Phase II Study of the CD38 Antibody Daratumumab in Patients With High-Risk MGUS and Low-Risk Smoldering Multiple Myeloma
Status: Enrolling, Phase II
Updated: 12/31/1969
Karmanos Cancer Insitute
mi
from
Detroit, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Niraparib, TSR-022, Bevacizumab, and Platinum-Based Doublet Chemotherapy in Combination With TSR-042
Status: Enrolling, Phase I
Updated: 12/31/1969
Karmanos Cancer Insitute
mi
from
Detroit, MI
Click here to add this to my saved trials